Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia

Translational Research

Volumn 159, Issue 6, 2012, Pages 497-506

  Henning, Robert J ^a   Dennis, Steve ^a   Sawmiller, Darrell ^a   Hunter, Lorynn ^a   Sanberg, Paul ^a   Miller, Leslie ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CORONARY ARTERY; CULTURE MEDIUM; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPOXIA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; UMBILICAL CORD; WESTERN BLOTTING;

EID: 84861602181     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.02.004     Document Type: Article

References (52)

1. A.D. Lopez, and C. Murray The global burden of disease, 1990-2020 Nat Med 4 1998 1241 1243
2. V. Roger, M. Turner American Heart Association Heart Disease and Stroke Statistics Writing Group Heart Disease and Stroke Statistics - 2011 Update Circulation 123 2011 e18 e209
3. R.J. Henning, H. Abu-Ali, and J.B. Balis Human umbilical cord stem cells in the treatment of acute myocardial infarction Cell Transplant 13 2004 729 739
4. R.J. Henning, J.D. Burgos, and L. Ondrovic Human umbilical cord stem cells are attracted to myocardial infarctions Cell Transplant 15 2006 647 658
5. R.J. Henning, J.D. Burgos, and M. Vasko Human umbilical cord stem cells and myocardial infarction: effect of dose and route of administration on infarct size Cell Transplant 16 2007 907 917
6. R.J. Henning, M. Shariff, and E. Ujwala Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute infarcts Stem Cells Dev 17 2008 1207 1220
7. R.J. Henning, J. Aufman, and M. Shariff Human umbilical cord stem cells decrease fibrosis and increase cardiac function in cardiomyopathy Regenerative Med 5 2010 45 54
8. H. Broxmeyer, M. Lee, and G. Hango Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5 year cryopreserved cord blood Blood 117 2011 4773 4777
9. H.E. Broxmeyer Cellular characteristics of cord blood and cord blood transplantation 1998 AABB Press Bethesda, Maryland
10. M. Kohli-Kumar, N.T. Shahidi, and H.E. Broxmeyer Haemopoietic stem/progenitor cell transplantation in Fanconi anemia using HLA matched umbilical cord blood cells Br J Haematol 85 1993 419 422
11. L. Lu, Y. Ge, Z.-H. Li, B. Breie, and D.W. Clapp CD34 stem/progenitor cells purified from cryopreserved normal cord blood can be transduced with high efficiency Cell Transplantation 4 1995 493 503
12. + unprimed T cells J Immunol 152 1994 5613 5623
13. M. Roncarolo, M. Bigler, E. Ciuti, S. Martino, and P. Tovo Immune responses by cord blood cells Blood Cells 20 1994 573 585
14. E. Rainsford, and D. Reen Interleukin 10, produced in abundance to human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation Br J Haematol 116 2006 702 709
15. R.J. Henning Stem cells in cardiac repair Future Cardiol 7 2011 99 117
16. M. Pesce, A. Orlandi, and M. Iachininoto Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues Circ Res 93 2003 e51 e62
17. D. Orlic, J. Kajstura, and S. Chimenti Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
18. R.J. Henning, D. Sawmiller, and D. Fleming Human umbilical cord blood stem cells secrete growth factors and anti-inflammatory cytokines that protect vascular endothelial cells and cardiac myocytes from ischemia and injury J Am Coll Cardiol 55 2010 A110
19. S. Neuhoff, J. Moers, and M. Rieks Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro Exp Hematol 235 2007 1119 1131
20. H. Arien-Zakay, S. Lecht, and M. Bercu Neuroprotection by cord blood progenitors involves antioxidants, neurotrophic and angiogenic factors Exp Neurol 216 2009 83 94
21. M. Majka, A. Janowska-Wieczorek, and J. Ratajczak Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner Blood 97 2001 3075 3085
22. M. Sussman, M. Volkers, and F. Fisher Myocardial AKT: The omnipresent nexus Physiological Reviews 91 2011 1023 1070
23. T. Matsui, J. Tao, and F. del Monte Akt preserves cardiac function and prevents injury Circulation 104 2001 330 335
24. A. Muslin Akt: a critical regulator of cardiomyocyte survival and metabolism Pediatr Cardiol 32 2011 317 322
25. B. Zordoky, and A. El-Kadi H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart J Pharmacol Toxicol Methods 56 2007 317 322
26. J. Hescheler, R. Meyer, S. Plant, D. Krautwurst, W. Rosenthal, and G. Schultz Morphological, biochemical and electrophysiological characterization of a clonal cell (H9c2) line from rat heart Circulation Res 61 1991 1476 1486
27. N. Berndt, H. Yang, and B. Trinczek The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane Cell Death Differ 17 2010 1795 1804
28. D. Kim, M. Sun, and L. He A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation J Biol Chem 285 2010 8383 8394
29. L. Yang, H. Dan, and M. Sun Akt/Protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt J Cancer Res 64 2004 4394 4399
30. D. Rowe, C. Leonardo, and J. Recio HUCB cells protect oligodendrocytes from brain ischemia through Akt signal transduction J Biol Chem 287 2012 4177 4187
31. T. Yamamura, H. Otani, and Y. Nakao IGF-1 differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart Am J Physiol Heart Circ Physiol 280 2001 H1191 H1200
32. Q. Li, B. Li, and X. Wang Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy J Clin Inves 100 1997 1991 1999
33. Y. Wang, N. Ahmad, M. Wani, and M. Ashraf Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis J Mol Cell Cardiol 37 2004 1041 1052
34. R. Hayward, T.O. Nossuli, and R. Scalia Cardioprotective effect of IL-10 Eur J Pharmacol 334 1997 157 163
35. S.P. Jones, and S.D. Trocha IL-10 Cardioprotective actions are independent of iNOS Am J Physiol Heart 281 2001 48 52
36. M. Davis, P. Hsieh, and T. Takahashi Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc Nat Acad Sci U S A 103 2006 8155 8160
37. Z. Tao, B. Chen, and Z. Tari Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation and reduces apoptosis in porcine myocardial infarction Proc Nat Acad Sci U S A 108 2011 2064 2069
38. L. Zhou, W. Ma, and Z. Yang VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinoisitol-3 kinase and Bcl-2 pathways Gene Ther 12 2005 196 202
39. Y. Fujio, T. Nguyen, D. Wencker, R. Kitsis, and K. Walsh Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667
40. C. Mullonkal, and L. Toledo-Pereyra Mechanisms for protection. Akt in ischemia and reperfusion J Invest Surg 20 2007 195 203
41. S. Datta, H. Dudek, and X. Tao Akt phosphorylation of BAD couples survival signals to cell intrinsic death machinery Cell 91 1997 231 241
42. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
43. J. Kajstura, W. Cheng, and K. Reiss Apoptotic and necrotic myocyte cell death Lab Invest 74 1996 86 107
44. T. Scarabelli, A. Stephanou, and N. Rayment Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury Circulation 104 2001 253 256
45. L.M. Buja Myocardial ischemia and reperfusion injury Cardiovas Path 14 2005 170 175
46. W. Lieberthal, S. Menza, and J. Levine Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells Am J Physiol 274 1998 F315 F327
47. E. Laufer, C. Reutelingsperger, J. Narula, and L. Hofstra Annexin A5: an imaging biomarker of cardiovascular risk Basic Res Cardiol 103 2008 95 104
48. E. Dumoni, C. Reutelingsperger, J. Smits, M. Daemen, P. Doevendans, and H. Wellens Real-time imagine of apoptotic cell membrane changes at the single-cell level in the beating murine heart Nat Med 7 2001 1352 1355
49. R. Overbeeke, H. Steffens-Nekken, I. Vermes, C. Reutelingsperger, and C. Haanen Early features of apoptosis detected by four different flow cytometry assays Apoptosis 3 1998 115 121
50. J. Tas, and G. Westerneng Fundamental aspects of the interaction of propidium diiodide with nucleic acids studied in a model system of polyacrylamide films J Histochem Cytochem 29 1981 929 936
51. K. Parmar, P. Mauch, J.-A. Vergilio, R. Sackstein, and J. Down Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia Proc Nat Acad Sci U S A 104 2007 5431 5436
52. Z. Ivanovic Hypoxia or in situ normoxia: the stem cell paradigm J Cell Physiol 219 2009 271 275